Emory launches new program to improve health equity by accelerating disease diagnostic research

December 18, 2023 | Saporta Report

Striving to ensure advanced medical technologies are reaching the populations who need them most,  Emory’s Center for the Advancement of Diagnostics for a Just Society  (ADJUST) is launching this year as part of NIH’s RADx program.

The last several years have demonstrated that new technologies are steadily allowing for the diffusion of disease diagnosis and monitoring out of clinical environments and into communities, businesses, schools, and homes. These types of point-of-care technologies offer numerous benefits, but they also introduce a whole new set of issues – not only technological and clinical, but also logistical, regulatory, commercial, social, and ethical. Often times, the patients who need these new technologies the most have the least access.

Emory’s new center is the first-of-its-kind designed to address these issues. Utilizing a two-pronged approach to accelerate diagnostic development while ensuring health equity and justice, the ADJUST Center will serve as both a thinktank focusing on the advancement of future disease diagnosis through research and advocacy, as well as a technology foundry to accelerate diagnostic development.

“Given our vast experience, expertise, and ecosystem in diagnostics, we are well poised to be the only center in the nation dedicated to advancing the entire field of diagnostics forward in this modern era of medicine,” says Wilbur Lam, MD, PhD, pediatric hematologist and oncologist at  Children’s Healthcare of Atlanta,   and professor of pediatrics and biomedical engineering at Emory University and Georgia Institute of Technology. “As we help develop and translate new diagnostic technologies, our Center will also concurrently address the issues of accessibility, usability, and affordability to ensure these state-of-art tests will serve the populations who need them the most.”

The ADJUST Center is borne out of the NIH-funded point-of-care technologies center, the  ACME POCT , which is one of six sites in the U.S. selected by NIH as part of the NIH Point-of-Care Technologies Research Network. ACME POCT played a pivotal role during the onset of the COVID-19 pandemic as the national test verification center to rapidly evaluate COVID-19 tests and help make them widely available.

The ADJUST Center will seek to build off the expertise compiled during the COVID-19 pandemic and apply the lessons learned and proven tactics to ensure equitable access to advanced technology for everyone. Projects already underway include assessing the potential adverse outcomes of consumer health wearable technologies and examining the availability of point-of-care HPV diagnostics.   

Emory’s Senior Vice President for Research Deborah Bruner, PhD, says, “The ADJUST Center is an important new initiative that builds upon Emory’s strengths and impacts so many of our institutional goals. It is highly innovative, it is entrepreneurial, it is collaborative, and it is focused on health equity – it encompasses a wide variety of things that make us Emory.  I’m extremely excited to see what the center can achieve for our community and the world.”

Source: https://saportareport.com/emory-launches-new-program-to-improve-health-equity-by-accelerating-disease-diagnostic-research/thought-leadership/higher-education/emory-university/

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS